intravenous treatment articles & resources on Made-in-China.com

Health Care Reform Survives a Lawsuit

Jan 21, 2014

The New York Times: Health Care Reform Survives A Lawsuit A long-shot lawsuit that could have damaged the effectiveness of health care reform got a well-deserved brushoff from a federal district judge on Wednesday. The suit was brought ...

Tags: New York Times, Alemtuzumab, Maternity Leave, FDA

Trevena Announced Today Initiation of Dosing in BLAST-AHF

Jan 10, 2014

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center ...

Tags: Trevena, GPCR biased ligands, BLAST-AHF, acute heart failure

Ceptaris Therapeutics Has Obtained FDA Marketing Approval for Valchlor

Aug 27, 2013

Ceptaris Therapeutics has obtained FDA marketing approval for Valchlor (mechlorethamine) gel to topically treat stage IA and IB mycosis fungoides-type cutaneous T-Cell lymphoma (CTCL) patients who were exposed to skin-directed therapy ...

Tags: Valchlor Gel, Ceptaris

Jennerex Starts Phase 2 Hcc Trial of Jx-594

Nov 27, 2012

Jennerex has treated the first patient in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma(HCC)who have not received treatment with sorafeni. The ...

Tags: hepatocellular carcinoma, JX-594, intravenous treatment, Jennerex

intravenous treatment

Health Care Reform Survives a Lawsuit

Trevena Announced Today Initiation of Dosing in BLAST-AHF

Ceptaris Therapeutics Has Obtained FDA Marketing Approval for Valchlor

Jennerex Starts Phase 2 Hcc Trial of Jx-594

Related Products